Version 1.2.0 of Accu-Chek Connect Diabetes Management App (iOS) released on July 11, 2016

FDA Device Recall #Z-0586-2017 — Class II — September 14, 2016

Recall Summary

Recall Number Z-0586-2017
Classification Class II — Moderate risk
Date Initiated September 14, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Diabetes Care, Inc.
Location Indianapolis, IN
Product Type Devices
Quantity 7,909 downloads of iOS version 1.2.0 of the Accu-Chek Connect Diabetes Management App in the US and 8,775 downloads Internationally

Product Description

Version 1.2.0 of Accu-Chek Connect Diabetes Management App (iOS) released on July 11, 2016

Reason for Recall

Roche Diabetes Care, Inc. initiated a voluntary recall for the version 1.2.0 of Accu-Chek Connect Diabetes Management App (iOS), released on July 11, 2016, due to the software containing a programming error (bug) in the Bolus Advisor feature, which could lead to an incorrect insulin bolus recommendation.

Distribution Pattern

US Distribution to the states of : Alabama, Arizona, Arkansas, California, Colorado, Connecticut, DC, Delaware, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Virginia, Washington, West Virginia, Wisconsin Foreign: None provided

Lot / Code Information

Version 1.2.0 of Accu-Chek Connect Diabetes Management App (iOS) released on July 11, 2016; Catalog number 07562462001 / GTIN number 00365702700000

Other Recalls from Roche Diabetes Care, Inc.

Recall # Classification Product Date
Z-2174-2024 Class II Accu-Chek Guide (SC) Kit -Intended to quantitat... May 13, 2024
Z-1008-2022 Class II RocheDiabetes Care Platform Software version 2.... Mar 9, 2022
Z-2351-2021 Class II Accu-Chek Aviva Plus Test Strip, Blood Glucose ... Jul 28, 2021
Z-2354-2021 Class II Accu-Chek Inform II Test Strip, Whole Blood Glu... Jul 28, 2021
Z-2353-2021 Class II Accu-Chek SmartView Test Strip, Blood Glucose M... Jul 28, 2021

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.